Andrew H. Miller spends much of his time researching Depression, Internal medicine, Immunology, Endocrinology and Psychiatry. When carried out as part of a general Depression research project, his work on Major depressive disorder is frequently linked to work in Child abuse, therefore connecting diverse disciplines of study. He combines subjects such as Antidepressant, Placebo, Alpha interferon and Indoleamine 2,3-dioxygenase with his study of Internal medicine.
His studies in Immunology integrate themes in fields like Neurotransmitter metabolism and Chronic stress. His Endocrinology research includes elements of Receptor and Monocyte. His Proinflammatory cytokine study combines topics in areas such as Chemokine, Cytokine and Pharmacology.
Internal medicine, Depression, Endocrinology, Inflammation and Immunology are his primary areas of study. His work carried out in the field of Internal medicine brings together such families of science as Alpha interferon and Oncology. Depression is a subfield of Psychiatry that Andrew H. Miller studies.
His Endocrinology study frequently links to adjacent areas such as Receptor. The study incorporates disciplines such as Tumor necrosis factor alpha, Glutamate receptor, Lung cancer and Neuroscience in addition to Inflammation. His study in Immune system and Proinflammatory cytokine falls within the category of Immunology.
Andrew H. Miller mainly investigates Internal medicine, Inflammation, Depression, Oncology and Cancer. Andrew H. Miller interconnects Endocrinology and Anxiety in the investigation of issues within Internal medicine. His Inflammation research is multidisciplinary, incorporating elements of Tumor necrosis factor alpha, Immune system and Anhedonia.
Immune system is a primary field of his research addressed under Immunology. His work on Peripheral blood as part of general Immunology study is frequently linked to Metabolic reprogramming, therefore connecting diverse disciplines of science. His Depression research is multidisciplinary, relying on both Longitudinal study, MEDLINE, Gastroenterology, Lung cancer and Cohort.
His primary areas of study are Inflammation, Internal medicine, Depression, Tumor necrosis factor alpha and Proinflammatory cytokine. His studies deal with areas such as Confounding, Dizygotic twin, Immune system and Anhedonia as well as Inflammation. His Internal medicine research integrates issues from Antidepressant and Anxiety.
He incorporates Depression and Lower risk in his research. Andrew H. Miller has researched Proinflammatory cytokine in several fields, including Dopaminergic, Dopamine and Neuroscience. His biological study deals with issues like Head and neck cancer, which deal with fields such as Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Andrew H. Miller;Vladimir Maletic;Charles L. Raison.
Biological Psychiatry (2009)
Cytokines sing the blues: inflammation and the pathogenesis of depression
Charles L. Raison;Lucile Capuron;Andrew H. Miller.
Trends in Immunology (2006)
Pituitary-Adrenal and Autonomic Responses to Stress in Women After Sexual and Physical Abuse in Childhood
Christine Heim;D. Jeffrey Newport;Stacey Heit;Yolanda P. Graham.
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Andrew H. Miller;Charles L. Raison.
Nature Reviews Immunology (2016)
The link between childhood trauma and depression: insights from HPA axis studies in humans.
Christine Heim;D. Jeffrey Newport;Tanja Mletzko;Andrew H. Miller.
When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders
Charles L. Raison;Andrew H. Miller.
American Journal of Psychiatry (2003)
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
Carmine M Pariante;Andrew H Miller.
Biological Psychiatry (2001)
Paroxetine for the Prevention of Depression Induced by High-Dose Interferon Alfa
Dominique L. Musselman;David H. Lawson;Jane F. Gumnick;Amita K. Manatunga.
The New England Journal of Medicine (2001)
Mood disorders in the medically ill: scientific review and recommendations.
Dwight L. Evans;Dennis S. Charney;Dennis S. Charney;Lydia Lewis;Robert N. Golden.
Biological Psychiatry (2005)
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression The Role of Baseline Inflammatory Biomarkers
Charles L. Raison;Robin E Rutherford;Bobbi J. Woolwine;Chen Shuo.
JAMA Psychiatry (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: